Wednesday, 25 November 2020

Dexamethasone May Down Efficacy of Checkpoint Inhibitor

Dexamethasone, when given at baseline for cerebral edema for patients with glioblastoma using checkpoint inhibitors, had significantly worse overall survival.


from Medindia Health News https://ift.tt/33jXRXA

No comments:

Post a Comment